Georgia Kounti
Overview
Explore the profile of Georgia Kounti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
77
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manali E, Kannengiesser C, Borie R, Ba I, Bouros D, Markopoulou A, et al.
Respiration
. 2022 Jan;
101(6):531-543.
PMID: 35078193
Background: Monogenic and polygenic inheritances are evidenced for idiopathic pulmonary fibrosis (IPF). Pathogenic variations in surfactant protein-related genes, telomere-related genes (TRGs), and a single-nucleotide polymorphism in the promoter of MUC5B...
2.
Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, et al.
Respir Res
. 2021 May;
22(1):140.
PMID: 33952261
Background: Idiopathic Pulmonary Fibrosis (IPF) represents a chronic lung disease with unpredictable course. Methods: We aimed to investigate prognostic performance of complete blood count parameters in IPF. Treatment-naïve patients with...
3.
Papiris S, Bouros D, Markopoulou K, Kolilekas L, Papaioannou A, Tzilas V, et al.
Eur Respir J
. 2020 Dec;
57(3).
PMID: 33334934
No abstract available.
4.
Antoniou K, Markopoulou K, Tzouvelekis A, Trachalaki A, Vasarmidi E, Organtzis J, et al.
ERJ Open Res
. 2020 Feb;
6(1).
PMID: 32010718
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety...